This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Klebsiella pneumoniae subsp. rhinoscleromatis: NCBI 39831, [subspecies]

Back to details

  1. Rhinoscleroma: The primary health impact of Klebsiella pneumoniae subsp. rhinoscleromatis is the development of rhinoscleroma. This condition typically manifests as nasal obstruction, nasal discharge, epistaxis (nosebleeds), and the formation of nodules or granulomatous lesions in the nasal passages. As the disease progresses, it can lead to deformities of the nasal structures and potentially affect nearby tissues and organs.

  2. Chronic Infection: Rhinoscleroma is characterized by its chronic nature, with the lesions slowly progressing over time if left untreated. The chronic inflammation and tissue damage associated with rhinoscleroma can lead to significant morbidity and functional impairment, particularly in advanced cases.

  3. Complications: In severe cases or when left untreated, rhinoscleroma can lead to complications such as secondary infections, septal perforation, destruction of nasal cartilage and bone, and even involvement of adjacent structures such as the larynx, trachea, and lungs. These complications can exacerbate the severity of symptoms and pose challenges for treatment.

  4. Rare Occurrence: Rhinoscleroma is considered a rare disease, and cases are primarily reported in regions where the condition is endemic, such as certain parts of Africa, Asia, and Central and South America. However, with increased global travel and migration, cases may also occur in non-endemic regions.

  5. Diagnostic Challenges: Diagnosing rhinoscleroma can be challenging, particularly in regions where the disease is not commonly encountered. It often requires a combination of clinical evaluation, imaging studies (such as computed tomography), and microbiological tests (such as culture and identification of Klebsiella pneumoniae subsp. rhinoscleromatis from nasal swabs or biopsy specimens).

  6. Treatment: Treatment of rhinoscleroma typically involves prolonged antibiotic therapy, often with multiple antibiotics in combination to target the bacteria effectively. In some cases, surgical intervention may be necessary to remove obstructive lesions or correct structural deformities caused by the disease.

Other Sources for more information:

Legend

Klebsiella pneumoniae subsp. rhinoscleromatis impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart

Other bacteria of the same rank impacting Klebsiella pneumoniae subsp. rhinoscleromatis

R2SlopeTax NameParent Chart
0.263504177331924440.6011069416999817Klebsiella variicola subsp. tropicaParent Taxa
0.2504577636718750.6201963424682617Klebsiella pneumoniae subsp. pneumoniaeParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]